Attached files
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS
ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002
Pursuant
to Section 905 of the Sarbanes-Oxley Act of 2002 (subsections (a)
and (b) of Section 1350, Chapter 63 of Title 18, United States
Code), I, Georges Benarroch, President, Chief Executive Officer and
Acting Chief Financial Officer of Kyto Biopharma, Inc., a Florida
corporation (the "Company"), do hereby certify, to the best of my
knowledge, that:
(1)
|
The
Company's Annual Report on Form 10-K for the period ended March 31,
2017, as filed with the Securities Exchange Commission on the date
hereof (the "Report") fully complies, in all material respects,
with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended; and
|
(2)
|
The
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company for the periods presented
therein.
|
|
|
|
|
|
|
|
|
Date: June
29, 2017
|
By:
|
/s/ Georges Benarroch
|
|
|
|
Georges
Benarroch
|
|
|
|
President,
Chief Executive Officer, principal executive officer, principal
financial and accounting officer
|
|
|
|
|
|